Education of patients taking capecitabine EORTC 10041 BIG 3-04 Intergroup Study MINDACT (Microarray In Node-negative Disease may Avoid ChemoTherapy): A.
A Phase I Study of MK-2206, an Oral Potent Allosteric Akt Inhibitor in Patients with Advanced Solid Tumors Anthony W. Tolcher, 1 Timothy A. Yap, 2 Ivy.
Jeffrey Schriber, M.D. FRCP (c) Medical Director Cancer Transplant Institute Virginia G. Piper Cancer Center Everything You Ever Wanted to Know About Transplant.
Redefining Non-small Cell Lung Cancer: The Role of Histology
Challenging Cases in Cancer: Advanced Breast Cancer
1 Press OW et al. Proc ASH 2011 ; Abstract 98. 2 Illidge T et al. Proc ASH 2011;Abstract 102.
